Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR control number DK-1577272925-2015000991 on 16-DEC-2015. Case received from a physician via HA on 14-DEC-2015 under the reference number DK-DKMA-WBS-0001994 and DK-DKMA-ADR 23270989. A 12-year-old female adolescent patient received GARDASIL (batch number unknown, Dose 1) in JAN-2012, GARDASIL (batch/lot number unknown, Dose 2) in MAR-2012, GARDASIL (batch number unknown, Dose 3) in JUL-2012. The patient experienced back pain in APR-2012, headache in JUL-2012, tiredness in JUL-2012, Musculoskeletal pain in APR-2012, pain from knees and hips under load in APR-2012, concentration impaired in connection to headache in JUL-2012 and decreased walking distance due to musculoskeletal pain in APR-2012. Have examinations and/or laboratory results been performed: Yes. Normal blood tests: red, white blood; picture metabolism, liver and bladder counts, electrolytes, mildly decreased vitamin D. Confirmed mild hypermobility. Investigated for Ehlers-Danlos. Not found. ECHO normal. The patient has been confirmed with mild hypermobility. No effect from physiotherapy. Giving up on training and physiotherapy. No other medications and vaccines. The case is assessed as serious due to disability. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166